ARCHIVES

NCI, FDA, Correlogic To Begin Large Trial Of Protein Pattern Diagnostic System for Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 26 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

DCT Board Sends Letter Opposing Bill Requiring Research On RU 486

November 13, 1992

Nexavar Phase III Trial Fails To Meet Primary Endpoint

June 29, 2012

In Brief: ACOS Analysis Finds Conclusive Shift To Modified Radical, Earlier Detection, Treatment For Blacks

September 4, 1981

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

April 13, 2012

Survivors Urge Congress To Include Oral Drug Coverage In Medicare Legislation

October 11, 2002

New Health Bills Could Affect Cancer Program

February 9, 1979